D
Denali Therapeutics Inc. DNLI
$15.15 $0.261.75%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 3.95% -7.89% -154.00% 7.27% -21.07%
Total Depreciation and Amortization -342.58% 2.35% -15.01% -78.48% -46.79%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 101.44% 8.84% -0.61% -90.54% -39.87%
Change in Net Operating Assets 80.46% 788.70% 97.39% -173.27% 792.98%
Cash from Operations 15.15% 32.31% 19.39% -93.22% -35.77%
Capital Expenditure -127.83% -87.81% 18.19% 22.83% 53.91%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 135.51% -5.28% -40.57% -401.55% 161.35%
Cash from Investing 135.75% -7.19% -41.35% -388.80% 157.27%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -11.69% 138.20% -25.09% 31,089.21% -98.43%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -188.59% -844.74% -25.09% 31,089.21% -98.43%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 503.37% -0.51% -77.93% 55.62% -121.03%
Weiss Ratings